The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data
- Dolling, David I.
- Goodall, Ruth L.
- Chirara, Michael
- Hakim, James
- Nkurunziza, Peter
- Munderi, Paula
- Eram, David
- Tumukunde, Dinah
- Spyer, Moira J.
- Gilks, Charles F.
- Kaleebu, Pontiano
- Dunn, David T.
- Pillay, Deenan
- Kaleebu, P.
- Pillay, D.
- Awio, P.
- Dunn, D.
- Gibb, D. M.
- Gilks, C.
- Kapaata, A.
- Katuramur, M.
- Lyagoba, F.
- Magambo, B.
- Mataruka, K.
- Mugarura, L.
- Musunga, T.
- Nabankkema, M.
- Nkalubo, J.
- Nkurunziza, P.
- Parry, C.
- Robertson, V.
Publication date
February 2017
DOI Publisher
Springer Science and Business Media LLC ISSN
1471-2334 Citation count (estimate)
2Abstract
Few low-income countries have virological monitoring widely available. We estimated the virological durability of first-line antiretroviral therapy (ART) after five years of follow-up among adult Ugandan and Zimbabwean patients in the DART study, in which virological assays were conducted retrospectively
Add to ORKG